发明名称 PYRROLIDINE DERIVATIVE
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a compound useful as a therapeutic and/or prophylactic agent of diabetes (type 2 diabetes or the like) and abnormality of glucose tolerance, and a prophylactic and/or improving agent of postprandial hyperglycemia, and having DPP4-inhibiting activities. <P>SOLUTION: The medicinal composition contains a compound represented by general formula (I) (wherein, R<SP>1</SP>, R<SP>2</SP>, R<SP>3</SP>, R<SP>4</SP>, R<SP>5</SP>and R<SP>6</SP>are each independently a hydrogen atom or a substituent; R<SP>7</SP>is a substituent; R<SP>8</SP>is a hydrogen atom, a protective group of a nitrogen atom, or the like; n is an integer of 0-4; when n is 2 or more, R<SP>7</SP>s may be the same or different; R<SP>1</SP>and R<SP>2</SP>may form a heterocycle in combination with the nitrogen atom bonded thereto; R<SP>1</SP>and R<SP>3</SP>may form a heterocycle by being bonded to each other; and R<SP>5</SP>and R<SP>6</SP>may form a carbon ring or a heterocycle in combination with the carbon atom bonded thereto), a salt thereof, a solvate thereof, an N-oxide thereof or a prodrug thereof as an active ingredient. <P>COPYRIGHT: (C)2007,JPO&INPIT</p>
申请公布号 JP2007001946(A) 申请公布日期 2007.01.11
申请号 JP20050185787 申请日期 2005.06.24
申请人 ONO PHARMACEUT CO LTD 发明人 KONMON TAKAHIRO;HATAKEYAMA AKIRA;KONDO TAKASHI;SAYAMA YUKINORI
分类号 C07D207/16;A61K31/401;A61K45/00;A61P1/04;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P5/06;A61P7/00;A61P7/06;A61P9/10;A61P13/08;A61P15/00;A61P15/08;A61P17/00;A61P17/02;A61P19/02;A61P25/08;A61P25/20;A61P25/22;A61P25/24;A61P31/18;A61P35/00;A61P35/04;A61P37/06;A61P37/08;A61P43/00 主分类号 C07D207/16
代理机构 代理人
主权项
地址